Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

BACKGROUND: Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19. Despite the ongoing controversies, HCQ was recommended for ma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Saudi Pharm J
Main Authors: Almazrou, Saja H., Almalki, Ziyad S., Alanazi, Abdullah S., Alqahtani, Abdulhadi M., Alghamd, Saleh M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527306/
https://ncbi.nlm.nih.gov/pubmed/33020690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.09.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados